Allbirds (NASDAQ:BIRD – Get Free Report) is scheduled to be announcing its earnings results after the market closes on Wednesday, May 8th. Analysts expect the company to announce earnings of ($0.21) per share for the quarter. Allbirds has set its Q1 2024 guidance at EPS and its FY 2024 guidance at EPS.Individual that are interested in participating in the company’s earnings conference call can do so using this link.
Allbirds (NASDAQ:BIRD – Get Free Report) last announced its earnings results on Tuesday, March 12th. The company reported ($0.22) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.22). Allbirds had a negative net margin of 60.01% and a negative return on equity of 51.83%. The company had revenue of $71.99 million for the quarter, compared to analysts’ expectations of $68.88 million. On average, analysts expect Allbirds to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.
Allbirds Stock Down 4.8 %
Shares of BIRD opened at $0.60 on Wednesday. Allbirds has a 52-week low of $0.54 and a 52-week high of $1.83. The firm’s fifty day moving average is $0.73 and its two-hundred day moving average is $0.91. The stock has a market cap of $93.63 million, a PE ratio of -0.60 and a beta of 1.82.
Analyst Upgrades and Downgrades
Read Our Latest Analysis on BIRD
Allbirds Company Profile
Allbirds, Inc manufactures and sells footwear and apparel products for men and women in the United States and internationally. The company offers a range of lifestyle and performance shoes; and apparel, including classic tees and sweats, socks, and underwear. It sells its products through its retail stores, as well as online.
See Also
- Five stocks we like better than Allbirds
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- NXP Semiconductors Will Set a New High Soon: $300 in Sight
- What is a Special Dividend?
- Hilton Demonstrates Asset Light is Right for Investors
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Boston Scientific Bucks the Medtech Slow Down and Raises Outlook
Receive News & Ratings for Allbirds Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allbirds and related companies with MarketBeat.com's FREE daily email newsletter.